Elexacaftor/Tezacaftor/Ivacaftor improves CFTR activity and pulmonary function in Cystic Fibrosis Patients carrying the N1303K Mutation
Resource Type
CF Research News
Authors
References
J Cyst Fibros. 2023 Jun 16;S1569-1993(23)00178-9. doi: 10.1016/j.jcf.2023.06.001.
Document
Link
Theme
Clinical Trials [4]
Pulmonology [5]
Date
Friday, June 16, 2023
Featured resource article
Yes
Resource - Guideline Type
Other Guidelines [6]